Arnhem, June 2009 The 4th ESU Master class on medical treatment for urological cancer is organised by the European School of Urology (ESU) on 27-28 June 2009 at the Barcel Hotel Sants in Barcelona, Spain. The format consists of three modules. Module 1 is entitled 'Hormonal and intravesical treatment and chemoprevention', module 2 'Immunotherapy and targeted therapies' and module 3 'Systemic cytotoxic chemotherapy and palliation'.
Each module comprises short state-of-the-art lectures followed by debates, case reports and interactive discussions. supplemented with case discussions and presentations. For the first time an online pre-assessment is included in the programme.
Professor Hein van Poppel, ESU course director: "The pre-assessment is meant to determine the level of a participant's knowledge before the start of the Masterclass. It is held online and consists of 20 multiple choice questions. The faculty will review the results and adjust the content of their lectures accordingly".
A post-assessment takes place after the last lecture and consists of 100 multiple choice questions to test the participant's knowledge on the topics taught during the ESU Masterclass.
This teaching programme has been developed by close collaboration between the European Association of Urology (EAU), the European School of Urology (ESU) and the European Board of Urology (EBU). "With rapid advances in cancer research, the oncologically oriented urologist requires insights on the clinical applicability and impact of the latest range of surgical and medical treatment strategies. The Masterclass is a prime venue to scrutinise current practices and survey the latest therapies that are still being tried or tested in various medical disciplines involved in cancer therapy", says Professor Ziya Kirkali, ESU course director. The ESU aims to provide a comprehensive update for urologists, but the Masterclass is open to other specialists, such as medical oncologists and radiotherapists. There is a significant gain in knowledge by viewing the same issues from different perspectives. The goal is to provide an overview of the different aspects of hormonal and intravesical treatment, chemoprevention, immunotherapy, targeted therapies and systemic cytotoxic chemotherapy and palliation, supplemented with case discussions and presentations. All participants receive a certificate acknowledging their participation.
|Contact: Lindy Brouwer|
European Association of Urology